Skip to content

Daily IssueFutureof Work

·

Daily Issue → inbox:

FFeed EExplore BBuild RRoles AAlerts YYou

●Last issue 3d ago

← Back to explore

N-Zyme Biomedical

nzymebio.com Company LinkedIn →

reflux trials

advance Phase 2 reflux programs testing pepsin inhibition for LPR and PPI-refractory GERD.

Funding Timeline

7/23/2026unknown$4.6M

7/23/2026series_a$4.6M

N-Zyme Biomedical | Funded Work